Haemolytic anaemia causing a marked bilirubin increase in a case of primary biliary cirrhosis;Hamolytische Anamie als Ursache eines auffalligen Bilirubinanstieges bei primarer biliarer Zirrhose

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 40, 1996, Pages 1226-

  Mahl, M A ^a   Schonfeld J V ^a   Uppenkamp, M ^a   Breuer, N ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; URSODEOXYCHOLIC ACID; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; LIVER TRANSPLANTATION; PRIMARY BILIARY CIRRHOSIS; BILIARY CIRRHOSIS; BLOOD; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; MIDDLE AGED;

ALKALINE PHOSPHATASE; ANEMIA, HEMOLYTIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MIDDLE AGED; URSODEOXYCHOLIC ACID;

EID: 0030568895     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043131     Document Type: Article

References (15)

1. Consensus statement on indications for liver transplantation: Paris, June 22-23, 1993. Hepatology 20 (1994), 63-68.
2. Balasubramaniam, K., P. M. Grambsch, R. H. Wiesner, K. D. Lindor, E. R. Dickson: Diminished survival in asymptomatic primary biliary cirrhosis. Gastroenterology 98 (1990), 1567-1571.
3. Benhamou, J. P.: Indications for liver transplantation in primary biliary cirrhosis. Hepatology 20 (1994), 11-13.
4. Christensen, E., D. G. Altman, J. Neuberger, B. L. de Stavola, N. Tygstrup, R. Williams, and the PBC1 and PBC2 Trial Groups: Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 105 (1993), 1865-1876.
5. Dickson, E. R., P. M. Grambsch, T. R. Fleming, L. D. Fisher, A. Langworthy: Prognosis in primary biliary cirrhosis. Model for decison making. Hepatology 10 (1989), 1-7.
6. Hume, R., J. M. Williamson, J. W. Whitelaw: Red cell survival in biliary cirrhosis. J. clin. Pathol. 23 (1970), 397-401.
7. Kaplan, M. M.: Primary biliary cirrhosis. New Engl. J. Med. 316 (1987), 521-528.
8. Klion, F. M., T. L. Fabry, M. Palmer, F. Schaffner: Prediction of survival of patients with primary biliary cirrhosis. Examination of the Mayo Clinic model on a group of patients with known endpoint. Gastroenterology 102 (1992), 310-313.
9. Lindor, K. D., E. R. Dickson, W. P. Baldus, R. A. Jorgensen, J. Ludwig, P. A. Murtaugh, J. M. Harrison, R. H. Wiesner, M. L. Anderson, S. M. Lange, G. Lesage, S. S. Rossi, A. F. Hofmann: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106 (1994), 1284-1290.
10. Orlin, J. B., E. M. Berkman, D. S. Matloff, M. M. Kaplan: Primary biliary cirrhosis and cold autoimmune hemolytic anemia. Effect of partial plasma exchange. Gastroenterology 78 (1980), 576-578.
11. Poupon, R. E., B. Balkau, E. Eschwege, R. Poupon, and the UDCA-PBC study group: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. New Engl. J. Med. 324 (1991), 1548-1554.
12. Poupon, R. E., R. Poupon, B. Balkau, and the UDCA-PBC study group: Ursodiol for the long-term treatment of primary biliary cirrhosis. New Engl. J. Med. 330 (1994), 1342-1347.
13. Thompson, N. P., S. Leader, C. P. Jamieson, W. R. Burnham, A. K. Burroughs: Reversible jaundice in primary biliary cirrhosis due to hyperthyroidism. Gastroenterology 106 (1994), 1342-1343.
14. Vuoristo, M., M. Färkkilä, A. L. Karvonen, R. Leino, J. Lehtola, J. Mäkinen, J. Mattila, C. Friman, K. Seppälä, J. Tuominen, T. A. Miettinen: A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 108 (1995), 1470-1478.
15. Wiesner, R. H., M. K. Porayko, E. R. Dickson, G. J. Gores, N. F. LaRusso, J. E. Hay, H. E. Wahlstrom, R. A. F. Krom: Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 16 (1992), 1290-1299.